GlassScriptPhysician profile
Josh Ryan Doll
NPI 1609972603
$78,717.21
in general payments reported to CMS, 2019-2025
42 companies · $8,361 in 2025
The $8,361 reported for 2025 was more than what 88% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $1,388 · 2020: $1,553 · 2021: $1,143 · 2022: $8,722 · 2023: $52K · 2024: $5,641 · 2025: $8,361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Consulting Fee: $8,050 · Food and Beverage: $7,296 · Travel and Lodging: $3,848 · Education: $20.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $46,697.00 |
| Consulting Fee | $8,050.00 |
| Food and Beverage | $7,296.49 |
| Travel and Lodging | $3,847.75 |
| Education | $20.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $67,940.96 | 2022-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $2,756.90 | 2019-2025 | Sapien 3 Ultra Resilia, Evoque, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $2,175.75 | 2019-2025 | Xience Skypoint, Diamondback Coronary, Dragonfly Opstar |
| Abiomed | $1,011.09 | 2019-2025 | Impella |
| Boston Scientific Corporation | $818.77 | 2019-2025 | Watchman Flx, Opticross |
| Medtronic, INC. | $406.11 | 2021-2024 | Onyx Frontier, Symplicity G3, Plasmablade(Tm) |
| Novartis Pharmaceuticals Corporation | $389.54 | 2019-2025 | |
| Inari Medical, INC. | $332.98 | 2020-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Atricure, INC. | $316.58 | 2021-2024 | |
| Celgene Corporation | $300.00 | 2022 | |
| Bristol Myers Squibb Company | $272.52 | 2023 | Camzyos |
| Medtronic Vascular, INC. | $214.08 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $187.15 | 2020-2024 | Andexxa |
| Shockwave Medical, INC | $180.85 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Amgen INC. | $143.68 | 2020-2025 | Repatha, Repatha |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $118.26 | 2020-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.51 | 2022-2025 | Jardiance |
| Cvrx, INC. | $104.90 | 2023-2025 | Barostim Neo System |
| Terumo Medical Corporation | $103.65 | 2022-2025 | Metacross Otw, Angio-Seal, Glidesheath Slender |
| Philips North America LLC | $100.20 | 2023-2025 | (5091) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided, (Cm9) Amb Mon & Diag Und |
| United Therapeutics Corporation | $100.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $88.28 | 2019-2024 | Xarelto |
| Alnylam Pharmaceuticals INC. | $81.15 | 2023-2024 | Onpattro |
| Kestra Medical Technology Services, INC. | $47.50 | 2023-2024 | Assure Wcd |
| Cardiva Medical, INC. | $45.84 | 2021-2025 | Cardiva Vascade 6/7f Vcs |
| Cardiovascular Systems INC. | $39.98 | 2019-2022 | |
| Biosense Webster, INC. | $37.66 | 2021 | |
| Pfizer INC. | $35.63 | 2022-2023 | |
| Chiesi USA, INC. | $34.49 | 2024-2025 | Kengreal |
| Sanofi-Aventis U.S. LLC | $23.37 | 2019 | |
| Convatec INC. | $22.39 | 2023 | |
| Novo Nordisk INC | $21.05 | 2021 | |
| Penumbra, INC. | $20.82 | 2023 | Indigo System |
| Kiniksa Pharmaceuticals International, Plc | $19.07 | 2024 | Arcalyst |
| Ethicon US, LLC | $18.19 | 2023 | Ethicon, Dermabond, Vistaseal |
| Bayer Healthcare Pharmaceuticals INC. | $17.89 | 2024 | |
| Abbvie INC. | $17.52 | 2023 | Qulipta |
| Cardinal Health 200 LLC | $16.55 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $16.08 | 2024 | |
| Angiodynamics, INC. | $15.64 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $15.63 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$17.85 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Josh Doll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.